Lamisil Treatment for Tinea Pedis (Athlete's Foot)
For athlete's foot, use topical terbinafine (Lamisil) 1% cream applied once or twice daily for 1 week for interdigital infections, or twice daily for 2 weeks for plantar/moccasin-type infections; alternatively, oral terbinafine 250 mg once daily for 1 week provides equivalent efficacy with faster clinical resolution. 1, 2
Treatment Algorithm
First-Line: Topical Terbinafine
For interdigital tinea pedis (between the toes):
- Apply terbinafine 1% cream twice daily (morning and night) for 1 week 2
- Mycological cure rates reach 91-93% with this regimen 3, 4
For plantar/moccasin-type tinea pedis (bottom or sides of foot):
- Apply terbinafine 1% cream twice daily for 2 weeks 2
- This hyperkeratotic form requires longer treatment duration
Alternative: Oral Terbinafine
When to use oral therapy:
- Severe or extensive disease
- Failed topical therapy
- Concomitant onychomycosis (nail involvement)
- Patient preference for shorter treatment course 1, 5
Dosing: Oral terbinafine 250 mg once daily for 1 week achieves similar mycological cure rates (approximately 90%) to 4 weeks of topical clotrimazole, but with faster clinical resolution 1
Comparative Efficacy
Terbinafine demonstrates superior efficacy compared to alternatives:
- vs. Clotrimazole: 93.5% vs. 73.1% mycological cure at 4 weeks with shorter treatment duration (1 week vs. 4 weeks) 4
- vs. Itraconazole: Similar mycological efficacy when oral terbinafine given for 1 week vs. itraconazole 100 mg for 2 weeks, but terbinafine shows slightly lower relapse rates 1
- vs. Placebo: Topical terbinafine achieves 91% cure vs. 37% with vehicle alone 3
Important Safety Considerations
Monitor for rare but serious adverse events:
- Isolated neutropenia (occasional)
- Liver failure (rare, typically in patients with pre-existing liver disease) 1
- Permanent taste disturbance (very rare but patients must be warned) 6
Contraindications:
- Active or chronic liver disease (systemic terbinafine not recommended) 6
Baseline monitoring recommended for:
- Heavy alcohol consumption history
- Known hepatitis
- Hematological abnormalities
- Children (terbinafine not licensed for pediatric onychomycosis, though well-tolerated) 6
Adjunctive Measures to Prevent Recurrence
Essential foot hygiene practices:
- Thorough drying between toes after showers (critical step)
- Daily sock changes
- Well-fitting, ventilated shoes
- Periodic cleaning of athletic footwear 1
Foot powder after bathing reduces tinea pedis rates from 8.5% to 2.1%, primarily by reducing T. mentagrophytes 1
Address predisposing factors:
- Treat concurrent conditions (obesity, diabetes are risk factors) 1
- Manage venous insufficiency or lymphedema
- Cover active foot lesions with socks before wearing underwear to prevent spread to groin 1
Common Pitfalls to Avoid
Inadequate treatment duration: Stopping topical therapy too early leads to recurrence. Complete the full 1-2 week course even if symptoms improve earlier.
Missing concomitant nail infection: If onychomycosis is present, topical foot treatment alone will fail. Oral therapy for 12-16 weeks is required for toenail infections 6.
Ignoring interdigital maceration: Fissures and maceration create entry points for bacterial superinfection (β-hemolytic streptococci), increasing erysipelas risk 7, 5.
Using fluconazole as first-line: Fluconazole shows inferior efficacy (63-71% response rate vs. 90-100% with terbinafine) and should only be used when patients cannot tolerate other agents 1.